• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sick Sinus Syndrome: More Than a Needle-in-a-haystack Manifestation of Immune Checkpoint Inhibitor-associated Myocarditis.

作者信息

Kadowaki Hiroshi, Akazawa Hiroshi

机构信息

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Japan.

出版信息

Intern Med. 2022 Jul 15;61(14):2101-2102. doi: 10.2169/internalmedicine.9033-21. Epub 2022 Mar 12.

DOI:10.2169/internalmedicine.9033-21
PMID:35283389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9381345/
Abstract
摘要

相似文献

1
Sick Sinus Syndrome: More Than a Needle-in-a-haystack Manifestation of Immune Checkpoint Inhibitor-associated Myocarditis.病态窦房结综合征：不止是免疫检查点抑制剂相关心肌炎的罕见表现
Intern Med. 2022 Jul 15;61(14):2101-2102. doi: 10.2169/internalmedicine.9033-21. Epub 2022 Mar 12.
2
Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis.窦房结功能障碍伴免疫检查点抑制剂相关性心肌炎。
Intern Med. 2022 Jul 15;61(14):2161-2165. doi: 10.2169/internalmedicine.8575-21. Epub 2022 Mar 12.
3
Cardiology patient pages. Sick sinus syndrome.心脏病患者专页。病态窦房结综合征。
Circulation. 2003 Nov 18;108(20):e143-4. doi: 10.1161/01.CIR.0000102938.55119.EC.
4
Beneficial effects of losartan for prevention of paroxysmal atrial fibrillation in patients with sick sinus syndrome: analysis with memory function of pacemaker.氯沙坦对病态窦房结综合征患者预防阵发性心房颤动的有益作用：基于起搏器记忆功能的分析
Heart Vessels. 2016 Mar;31(3):402-7. doi: 10.1007/s00380-015-0627-7. Epub 2015 Mar 19.
5
[Factors influencing development of atrial fibrillation after implantation of cardiac pacemaker for sinus node dysfunction].[影响心脏起搏器植入治疗窦房结功能障碍后房颤发生的因素]
Medicina (Kaunas). 2009;45(3):169-76.
6
Right versus left atrial pacing in patients with sick sinus syndrome and paroxysmal atrial fibrillation (Riverleft study): study protocol for randomized controlled trial.病态窦房结综合征合并阵发性心房颤动患者右心房起搏与左心房起搏的比较（Riverleft研究）：一项随机对照试验的研究方案
Trials. 2014 Nov 17;15:445. doi: 10.1186/1745-6215-15-445.
7
[Frequent falls in a patient with a pacemaker].[一名有起搏器患者的频繁跌倒]
Duodecim. 2005;121(19):2120.
8
Prevalence and clinical implications of atrial fibrillation episodes detected by pacemaker in patients with sick sinus syndrome.起搏器检测到的病态窦房结综合征患者房颤发作的患病率及临床意义
Heart. 2005 Mar;91(3):362-4. doi: 10.1136/hrt.2003.027219.
9
Dizziness during atrial antitachycardia pacing: What is the cause.心房抗心动过速起搏时头晕：原因是什么。
J Cardiovasc Electrophysiol. 2020 Nov;31(11):3036-3041. doi: 10.1111/jce.14728. Epub 2020 Sep 3.
10
Sick sinus syndrome as the early manifestation of cardiac hemochromatosis.病态窦房结综合征作为心脏血色素沉着症的早期表现。
J Electrocardiol. 1994 Jan;27(1):91-6. doi: 10.1016/s0022-0736(05)80114-1.

引用本文的文献

1
Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases.免疫检查点抑制剂相关心肌炎：已报道临床病例综述
Diagnostics (Basel). 2023 Mar 25;13(7):1243. doi: 10.3390/diagnostics13071243.

本文引用的文献

1
Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis.窦房结功能障碍伴免疫检查点抑制剂相关性心肌炎。
Intern Med. 2022 Jul 15;61(14):2161-2165. doi: 10.2169/internalmedicine.8575-21. Epub 2022 Mar 12.
2
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.免疫检查点抑制剂相关的心血管免疫毒性：安全性荟萃分析。
Eur Heart J. 2021 Dec 21;42(48):4964-4977. doi: 10.1093/eurheartj/ehab618.
3
Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events.免疫检查点抑制剂相关心脏不良事件的机制与管理
JMA J. 2021 Apr 15;4(2):91-98. doi: 10.31662/jmaj.2021-0001. Epub 2021 Apr 2.
4
Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology.癌症治疗相关心肌炎：心血管肿瘤学中新兴临床综合征的拟议病例定义。
Circulation. 2019 Jul 2;140(2):80-91. doi: 10.1161/CIRCULATIONAHA.118.034497.
5
Cardiovascular toxicities associated with immune checkpoint inhibitors.免疫检查点抑制剂相关的心血管毒性。
Cardiovasc Res. 2019 Apr 15;115(5):854-868. doi: 10.1093/cvr/cvz026.
6
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.免疫检查点抑制剂相关的心血管毒性：一项观察性、回顾性、药物警戒研究。
Lancet Oncol. 2018 Dec;19(12):1579-1589. doi: 10.1016/S1470-2045(18)30608-9. Epub 2018 Nov 12.
7
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.免疫检查点抑制剂相关致命性毒性作用：系统评价和荟萃分析。
JAMA Oncol. 2018 Dec 1;4(12):1721-1728. doi: 10.1001/jamaoncol.2018.3923.
8
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.免疫检查点抑制剂治疗患者的心肌炎。
J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19.
9
Fulminant Myocarditis with Combination Immune Checkpoint Blockade.暴发性心肌炎合并免疫检查点阻断治疗
N Engl J Med. 2016 Nov 3;375(18):1749-1755. doi: 10.1056/NEJMoa1609214.